2.47
3.01%
-0.02
前日終値:
$2.49
開ける:
$2.56
24時間の取引高:
98,979
Relative Volume:
0.58
時価総額:
$85.65M
収益:
-
当期純損益:
$-28.30M
株価収益率:
-3.6415
EPS:
-0.6783
ネットキャッシュフロー:
$-21.30M
1週間 パフォーマンス:
-17.86%
1か月 パフォーマンス:
-8.87%
6か月 パフォーマンス:
-51.89%
1年 パフォーマンス:
-76.73%
Genelux Corp Stock (GNLX) Company Profile
名前
Genelux Corp
セクター
電話
805-267-9889
住所
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
GNLX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
GNLX | 2.53 | 85.65M | 0 | -28.30M | -21.30M | -0.6783 |
VRTX | 447.05 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 741.71 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 589.15 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 248.84 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 102.92 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-08-28 | 開始されました | ROTH MKM | Buy |
2023-11-27 | 開始されました | H.C. Wainwright | Buy |
2023-09-12 | 開始されました | Maxim Group | Buy |
2023-02-15 | 開始されました | The Benchmark Company | Speculative Buy |
Genelux Corp (GNLX) 最新ニュース
Genelux shares target cut, maintains buy rating on 3Q earnings - Investing.com
Genelux reports Q3 EPS (19c), consensus (19c) - TipRanks
Genelux Corp. Releases New Corporate Presentation - TipRanks
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - Yahoo Finance
Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well - Yahoo Finance
Guggenheim Begins Coverage on Genelux (NASDAQ:GNLX) - Defense World
Guggenheim sees upside in Genelux shares, targets $8 as pivotal cancer trial progresses - Investing.com India
Brokerages Set Genelux Co. (NASDAQ:GNLX) PT at $22.33 - MarketBeat
Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp - Yahoo Finance
Genelux doses first subject in Phase II trial of NSCLC treatment - Yahoo Finance
Genelux advances NSCLC treatment with Phase 2 Olvi-Vec trial - Investing.com
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer - Yahoo Finance
Cubist Systematic Strategies LLC Takes $56,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World
Genelux Co. (NASDAQ:GNLX) Shares Sold by Renaissance Technologies LLC - Defense World
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit - Yahoo Finance
Genelux announces executive departure By Investing.com - Investing.com Australia
Genelux announces executive departure - Investing.com
Point72 Asia Singapore Pte. Ltd. Acquires Shares of 20,162 Genelux Co. (NASDAQ:GNLX) - Defense World
Affinity Asset Advisors LLC Acquires New Position in Genelux Co. (NASDAQ:GNLX) - Defense World
Highbridge Capital Management LLC Invests $1.23 Million in Genelux Co. (NASDAQ:GNLX) - Defense World
Short Interest in Genelux Co. (NASDAQ:GNLX) Decreases By 7.3% - MarketBeat
Genelux corp insider sells over $170k in company stock - Investing.com India
Genelux director Tyree James L sells shares worth over $4,400 - Investing.com India
Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells $63,134.10 in Stock - MarketBeat
Genelux corp insider sells over $196k in company stock - Investing.com
ROTH MKM analysts initates a Buy rating for Genelux Corp (GNLX) - Knox Daily
Genelux Corp insider sells $89.6k in company stock By Investing.com - Investing.com Australia
Genelux Corp insider sells $89.6k in company stock - Investing.com India
Insider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 42,818 Shares of Stock - MarketBeat
Genelux Corp [NASDAQ: GNLX] Sees Increase in Stock Value - Knox Daily
Genelux Corp (GNLX) Stock: A Year of Decreases and Increases - The InvestChronicle
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference - Yahoo Finance
Genelux Corp (GNLX) may enjoy gains as insiders got busy in the recent days - Knox Daily
Aladar Szalay Sells 107,045 Shares of Genelux Co. (NASDAQ:GNLX) Stock - Defense World
Genelux Corp insider sells over $550k in company stock - Investing.com India
Analysts Set Genelux Co. (NASDAQ:GNLX) Price Target at $26.75 - MarketBeat
Genelux (NASDAQ:GNLX) Upgraded to Strong-Buy by Roth Capital - Defense World
Genelux Corp [GNLX] Insider Activity: An Update for Investors - Knox Daily
Genelux Co. (NASDAQ:GNLX) Major Shareholder Aladar Szalay Sells 40,000 Shares - Defense World
Genelux (NASDAQ:GNLX) Receives New Coverage from Analysts at Roth Mkm - Defense World
Genelux (NASDAQ:GNLX) Coverage Initiated at Roth Mkm - MarketBeat
Genelux shares gain on Roth/MKM Buy rating, $10 price target - Investing.com
Genelux initiated with a Buy at Roth MKM - TipRanks
Equities Analysts Offer Predictions for Genelux Co.’s Q3 2024 Earnings (NASDAQ:GNLX) - Defense World
Genelux Co. (NASDAQ:GNLX) Sees Large Decrease in Short Interest - MarketBeat
Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth? - Yahoo Finance
Genelux's (GNLX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
GNLX Stock Earnings: Genelux Beats EPS for Q2 2024 - MSN
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates - StockTitan
Genelux (NASDAQ:GNLX) Trading Down 6.6% - Defense World
Genelux (NASDAQ:GNLX) Stock Price Down 6.6% - MarketBeat
Genelux Corp (GNLX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):